Overview

Join us for an in-depth look at managing supply chain risk under FDA’s QMSR. Since the final rule of FDA’s QMSR passed, harmonizing with ISO 13485, an increased emphasis has been placed on the management of risk. Arguably, nothing poses a greater risk to medical device organizations and to healthcare product availability than risks in the supply chain. Something so business-critical that can be affected by events that seem out of your organization’s control can feel alarming.

That’s why in this webinar, we’ll be looking at how you can build a resilient supply chain that will help your organization to ride the waves of supply chain instability. From building strong relationships with suppliers and manufacturers, to creating a robust quality management system as a foundation for a secure supply chain, join Ideagen and Joanne Rupprecht for an insightful webinar on how to manage risk and challenges ahead.

Key takeaways

You will gain an in-depth understanding of supply chain risks
Learn about the role and mission of FDA in ensuring healthcare product availability
Get an outline of the supply-chain-specific requirements in QMSR
Gain an insight into using electronic systems for the upkeep of a healthy, secure supply chain
Get expert insight into which goals should be prioritized when assessing and managing supply chain risk
Insight into the role healthcare supply chain risk plays in relation to 21 CFR 820 and ISO 13485
Learn how to build supply chain resilience and avoid disruptions
A summary of the regulatory landscape and key expectations that protect healthcare supply chains

Managing supply chain risk under FDA’s QMSR final rule